Chronic Kidney Disease News

Diality has received FDA 510(k) clearance for its Moda-flx Hemodialysis System for acute and/or chronic renal failure, according to a press release.

Dapagliflozin may have a protective effect on kidney function in patients with chronic kidney disease associated with autosomal dominant polycystic kidney disease, data show.

Bayer announced positive top-line results for the FINEARTS-HF trial of finerenone, in which the drug reduced risk for cardiovascular death and heart failure events in patients with HF with preserved or mildly reduced ejection fraction.

Patients who have diabetes at the time of kidney allograft loss may have a lower chance of survival compared without, according to .

A survey among patients and home dialysis nurses indicated that noise levels and setup time were key issues when using automated peritoneal dialysis machines.

Patients with advanced chronic kidney disease may benefit from angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use, but the antihypertensive agents may not reduce mortality risk, a retrospective analysis shows.

There may be a link between dietary fiber intake and hyperkalemia in patients on maintenance hemodialysis, according to a published cross-sectional study.

Hyperkalemia may be considered a common occurrence in patients with chronic kidney disease, particularly in those with heart failure or diabetes, published data show.

Incident cardiovascular and thromboembolic events may be more closely linked to the severity of kidney disease than with glomerular disease subtype, according to results of a prospective study.

Slowing the progression to advanced diabetic kidney disease could lower the economic impact of the condition and help health care systems optimize resources, recently published data show.